New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development-Reference-Cited by-同舟云学术

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

Published:2010-12 Issue:12 Volume:19 Page:1503-1514
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opin. Investig. Drugs

Author:

Di Maio Massimo,Morabito Alessandro,Piccirillo Maria Carmela,Daniele Gennaro,Giordano Pasqualina,Costanzo Raffaele,Riccardi Marita Georgia,Rocco Gaetano,Normanno Nicola,Perrone Francesco

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2010.532122

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lonely driver or the orchestra of mutations? How next generation sequencing datasets contradict the concept of single driver checkpoint mutations in solid tumours – NSCLC as a scholarly example;Seminars in Cancer Biology;2019-10

2. Sulfated liposaccharides inspired by telomerase inhibitor axinelloside A;Tetrahedron Letters;2017-12

3. Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology;Clinical Lung Cancer;2014-05

4. Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer;Drugs;2012-06

5. Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer;Expert Opinion on Biological Therapy;2011-08